Of late, KCNQ1OT1 was observed to support ubiquitin-specific peptidase 22 (USP22)-mediated stabilization of PD-L1 by deactivating miR-30a-5p and thereby inhibiting the anti-cancer immunity of CD8+ T cells [127]. This evidence concerns the gene KCNQ1OT1 and cancer.